Growing community of inventors

Madison, AL, United States of America

Majed Matar

Average Co-Inventor Count = 4.85

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 224

Majed MatarJason Fewell (11 patents)Majed MatarKhursheed Anwer (11 patents)Majed MatarGregory Slobodkin (6 patents)Majed MatarDanny H Lewis (5 patents)Majed MatarBrian Jeffery Sparks (4 patents)Majed MatarRichard Congo (4 patents)Majed MatarJennifer Rice (3 patents)Majed MatarJason G Fewell (1 patent)Majed MatarJason G Fewell (0 patent)Majed MatarMajed Matar (11 patents)Jason FewellJason Fewell (12 patents)Khursheed AnwerKhursheed Anwer (12 patents)Gregory SlobodkinGregory Slobodkin (6 patents)Danny H LewisDanny H Lewis (30 patents)Brian Jeffery SparksBrian Jeffery Sparks (6 patents)Richard CongoRichard Congo (4 patents)Jennifer RiceJennifer Rice (3 patents)Jason G FewellJason G Fewell (2 patents)Jason G FewellJason G Fewell (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Clsn Laboratories, Inc. (6 from 6 patents)

2. Egen, Inc. (5 from 8 patents)


11 patents:

1. 9827331 - Nucleic acid-lipopolymer compositions

2. 9468687 - Immuno gene therapy for treatment of cancer and hyperproliferative diseases

3. 9254334 - Polyamine derivatives

4. 9144546 - Nucleic acid-lipopolymer compositions

5. 8932638 - Polyamine derivatives

6. 8900621 - Polyamine derivatives

7. 8623837 - Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases

8. 8460696 - Polyamine derivatives

9. 8445017 - Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof

10. 8057821 - Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof

11. 7964571 - Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/14/2025
Loading…